⌘K
Loading ticker…
Vor Biopharma Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Vor Biopharma Inc. Common Stock (VOR) has a 3-month relative strength percentile of 70 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 52. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.0%, relative volume 8.64×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
70 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
VOR is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $19M notional. Top 3 carry $42M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $19M |
| XBIState Street SPDR S&P Biotech ETF | 0.22% | $17M |
| VXFVanguard Extended Market ETF | 0.01% | $6M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VOR Jan avg: 2.20% median: 0.80% win: 50% σ: 19.97% n: 4 2022-04-12 → 2026-05-29 | VOR Feb avg: 0.18% median: 2.94% win: 50% σ: 17.89% n: 4 2022-04-12 → 2026-05-29 | VOR Mar avg: -4.64% median: -0.27% win: 50% σ: 20.85% n: 4 2022-04-12 → 2026-05-29 | VOR Apr avg: -13.11% median: -17.29% win: 20% σ: 12.50% n: 5 2022-04-12 → 2026-05-29 | VOR May avg: -21.70% median: -21.51% win: 40% σ: 30.99% n: 5 2022-04-12 → 2026-05-29 | VOR Jun avg: 167.07% median: -3.94% win: 50% σ: 362.95% n: 4 2022-04-12 → 2026-05-29 (current) | VOR Jul avg: 2.79% median: -4.69% win: 25% σ: 16.82% n: 4 2022-04-12 → 2026-05-29 | VOR Aug avg: -4.16% median: -5.36% win: 25% σ: 11.72% n: 4 2022-04-12 → 2026-05-29 | VOR Sep avg: -8.47% median: -17.56% win: 25% σ: 21.63% n: 4 2022-04-12 → 2026-05-29 | VOR Oct avg: -5.84% median: 3.15% win: 50% σ: 33.84% n: 4 2022-04-12 → 2026-05-29 | VOR Nov avg: -17.41% median: -2.64% win: 25% σ: 32.11% n: 4 2022-04-12 → 2026-05-29 | VOR Dec avg: 39.15% median: 38.98% win: 100% σ: 15.16% n: 4 2022-04-12 → 2026-05-29 |